Stryker (SYK) Asset Writedowns and Impairment (2010 - 2026)
Stryker's (SYK) quarterly Asset Writedowns and Impairment came in at $1.0 million in Q2 2026, down 98.18% year-over-year from $55.0 million in Q2 2025, and down 85.71% quarter-over-quarter from $7.0 million in Q4 2025.
Analysis
Stryker (SYK) Asset Writedowns and Impairment (2010 - 2026) Analysis & Trends
Stryker (SYK) has reported Asset Writedowns and Impairment for 11 consecutive years, with $1.0 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Asset Writedowns and Impairment fell 98.18% year-over-year to $1.0 million in Q2 2026; TTM through Jun 2026 was $81.0 million, a 92.27% decrease from a year earlier, with the FY2025 full-year figure at $170.0 million, down 82.6% from the prior year.
- Asset Writedowns and Impairment was $1.0 million for Q2 2026 at Stryker, down from $7.0 million in the prior quarter.
- Over five years, Asset Writedowns and Impairment peaked at $956.0 million in Q4 2024 and troughed at $1.0 million in Q2 2023.
- A 5-year average of $102.7 million and a median of $16.0 million in 2024 frame the typical range for Asset Writedowns and Impairment.
- Across the five-year window, Asset Writedowns and Impairment soared 3883.33% in 2024 and plunged 99.27% in 2025, its largest moves.
- Over 5 years, Asset Writedowns and Impairment stood at $252.0 million in 2022, then slumped by 90.48% to $24.0 million in 2023, then soared by 3883.33% to $956.0 million in 2024, then sank by 99.27% to $7.0 million in 2025, then sank by 85.71% to $1.0 million in 2026.
- The last three Asset Writedowns and Impairment figures came in at $1.0 million (Q2 2026), $7.0 million (Q4 2025), and $73.0 million (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.54 Bn | 177.93 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 124.70 Bn | 119.48 Bn | 1.96 Bn |
| 3 | Medtronic | 117.91 Bn | 109.09 Bn | 6.34 Bn |
| 4 | Stryker | 105.72 Bn | 102.25 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.52 Bn | 45.27 Bn | 1.35 Bn |
| 7 | Alcon | 33.89 Bn | 32.43 Bn | 1.68 Bn |
| 8 | Dexcom | 32.10 Bn | 30.15 Bn | 830.00 Mn |
| 9 | Steris | 21.06 Bn | 20.58 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 18.26 Bn | 17.85 Bn | 1.54 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.00 Mn |
| Dec 31, 2025 | 7.00 Mn |
| Sep 30, 2025 | 73.00 Mn |
| Jun 30, 2025 | 55.00 Mn |
| Mar 31, 2025 | 35.00 Mn |
| Dec 31, 2024 | 956.00 Mn |
| Sep 30, 2024 | 2.00 Mn |
| Jun 30, 2024 | 16.00 Mn |
| Mar 31, 2024 | 3.00 Mn |
| Dec 31, 2023 | 24.00 Mn |
| Sep 30, 2023 | 9.00 Mn |
| Jun 30, 2023 | 1.00 Mn |
| Mar 31, 2023 | 2.00 Mn |
| Dec 31, 2022 | 252.00 Mn |
| Sep 30, 2022 | 105.00 Mn |
| Dec 31, 2021 | 145.00 Mn |
| Sep 30, 2021 | 105.00 Mn |
| Dec 31, 2020 | 54.00 Mn |
| Sep 30, 2020 | 189.00 Mn |
| Jun 30, 2020 | 189.00 Mn |